Buy WEGOVY 0.5MG Online in USA - Lowest Price $230.00
Configure Prescription
About WEGOVY 0.5MG
Wegovy 0.5MG is a once-weekly semaglutide injection used as part of the dose-escalation phase for chronic weight management. It helps further reduce appetite and supports progressive weight loss under medical supervision.
What is it used for?
Wegovy 0.5MG contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist developed by Novo Nordisk. It is indicated for long-term weight management in adults with obesity or overweight with weight-related medical conditions.
The 0.5MG dose is typically prescribed after completing 4 weeks of the 0.25MG starting dose. It continues the gradual dose increase process to:
- Enhance appetite suppression
- Increase satiety after meals
- Reduce calorie intake
- Support steady and sustainable weight loss
Wegovy is administered as a subcutaneous injection once weekly, in the abdomen, thigh, or upper arm, on the same day each week.
How to use
- Supports continued weight reduction
- Improves appetite control
- Once-weekly convenient dosing
- Gradual titration helps minimize side effects
Side Effects
Common side effects:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal discomfort
- Decreased appetite
Serious but rare side effects:
- Pancreatitis
- Gallbladder disease
- Severe dehydration
- Possible thyroid tumor risk (in predisposed individuals)
